Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DTBX40
|
|||
| Drug Name |
ALS-4
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Staphylococcus infection [ICD-11: 1B5Y; ICD-10: A49.0; ICD-9: 001-139] | Phase 1 | [1] | |
| Company |
Aptorum
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05274802) A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of ALS-4 (IM032) Administered Orally to Healthy Volunteers. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.